Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Comparing data across different chemistries/throughputs.

    Hi All,

    I have data from 6 RNA-Seq runs that we did sometime last year on a HiSeq machine. A month ago we tried the new MiSeq sequencer and I have one data-set from the new machine. How valid would be comparison between the two data-sets. Specifically, I have the following question.

    Would it be valid to compare these two data-sets. Especially considering that we get FPKM which would technically make comparison possible as the data-sets are independent of read-depth.

    Thanks in advance.
    Sameet Mehta (Ph.D.),
    Visiting Fellow,
    National Cancer Insitute,
    Bethesda,
    US.

  • #2
    Hum. I haven't been on SeqAnswers for several days and am sort of surprised that no-one answered your question. I see no problems with comparing the two data sets assuming that the FPKMs are valid.

    Comment


    • #3
      in one of our studies we compared data from the 454 FLX and 454 Junior machines. There is no reason why results should not be comparable. Plenty of studies compare and use data from different chemistries..... You should however do a thorough assessment of the error distributions between them. If they are not comparable, that is interesting in its own right.
      We are moving from 454 to MiSeq at the moment...one thing will be to compare the results between these data sets. These kind of questions need to be looked at with more rigour. Seeing as I am an Illumina greenhorn...are FPKM values some kind of quality score for contigs or sequences?
      If so, you are right that you really want to be comparing data of similar quality. We omitted a bunch of data which despite being at the same quality as a replicate data set, the mean depths were significantly different thus making accurate comparisons impossible. This all comes down to careful consideration of what goes into a run.
      j

      Comment

      Latest Articles

      Collapse

      • seqadmin
        Advancing Precision Medicine for Rare Diseases in Children
        by seqadmin




        Many organizations study rare diseases, but few have a mission as impactful as Rady Children’s Institute for Genomic Medicine (RCIGM). “We are all about changing outcomes for children,” explained Dr. Stephen Kingsmore, President and CEO of the group. The institute’s initial goal was to provide rapid diagnoses for critically ill children and shorten their diagnostic odyssey, a term used to describe the long and arduous process it takes patients to obtain an accurate...
        12-16-2024, 07:57 AM
      • seqadmin
        Recent Advances in Sequencing Technologies
        by seqadmin



        Innovations in next-generation sequencing technologies and techniques are driving more precise and comprehensive exploration of complex biological systems. Current advancements include improved accessibility for long-read sequencing and significant progress in single-cell and 3D genomics. This article explores some of the most impactful developments in the field over the past year.

        Long-Read Sequencing
        Long-read sequencing has seen remarkable advancements,...
        12-02-2024, 01:49 PM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by seqadmin, 12-17-2024, 10:28 AM
      0 responses
      33 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 12-13-2024, 08:24 AM
      0 responses
      49 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 12-12-2024, 07:41 AM
      0 responses
      34 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 12-11-2024, 07:45 AM
      0 responses
      46 views
      0 likes
      Last Post seqadmin  
      Working...
      X